Stockhub

pre-exposure prophylaxis (Q7239230)

Item Discussion
HIV prevention strategy using preventative medication for HIV-negative individuals
  • PrEP
edit
Language Label Description Also known as
British English
pre-exposure prophylaxis
HIV prevention strategy using preventative medication for HIV-negative individuals
  • PrEP

Statements

Freebase ID
/m/0dd33v
1 reference
stated in
Q15241312 (Deleted Item)
publication date
28 October 2013
instance of
Q179661 (Deleted Item)
0 references
pharmaceutical drug
0 references
short name
PrEP (English)
0 references
PrEP (Deutsch)
0 references
approved by
Q16 (Deleted Item)
start time
26 February 2016
1 reference
reference URL
https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?linkID=RDS00107
title
Regulatory Decision Summary - TRUVADA (English)
Belgium
start time
1 Haziran 2017
determination method
Q957712 (Deleted Item)
2 references
title
Geneesmiddel in PrEp om een HIV-infectie te voorkomen: terugbetaling vanaf 1 juni 2017 (Nederlands)
reference URL
https://www.inami.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/terugbetalen/specialiteiten/wijzigingen/Paginas/geneesmiddelen-PrEp-HIV.aspx
title
Lijst van de vergoedbare farmaceutische specialiteiten (Nederlands)
section, verse or paragraph
Hoofdstuk IV, § 8750000
Scotland
start time
10 April 2017
determination method
Q16933548 (Deleted Item)
1 reference
title
emtricitabine/tenofovir disoproxil (Truvada®) is accepted for use within NHS Scotland. (English)
author
Q81135628 (Deleted Item)
reference URL
https://www.scottishmedicines.org.uk/medicines-advice/emtricitabinetenofovir-disoproxil-truvada-fullsubmission-122517/
retrieved
29 December 2021
Australia
start time
2 Mayıs 2016
1 reference
reference URL
https://www.tga.gov.au/node/732814
title
Australian Public Assessment Reportfor tenofovir disoproxil fumarate /emtricitabine (English)
European Economic Area
start time
18 August 2016
determination method
marketing authorisation
3 references
main regulatory text
Q2517574
main regulatory text
Q110300868 (Deleted Item)
section, verse or paragraph
17(2)
20(7)(a)
title
Commission Implementing Decision of 18.8.2016 Amending the Marketing Authorisation Granted by Decision C(2005)456 for “truvada - Emtricitabine / Tenofovir Disoproxil Fumarate”, a Medicinal Product for Human Use (English)
reference URL
https://ec.europa.eu/transparency/documents-register/detail?ref=C(2016)5439
Ukraine
determination method
Q101965 (Deleted Item)
0 references
Aruba
0 references
Netherlands
0 references
Curaçao English
0 references
Sint Maarten English
0 references
MeSH
D065129
named as
Pre-Exposure Prophylaxis
0 references
Encyclopædia Britannica Online ID
topic/pre-exposure-prophylaxis
0 references
Commons category
Pre-exposure prophylaxis
0 references
Library of Congress authority ID
sh2017003696
0 references
MeSH Code
N02.421.726.758.655
0 references
N06.850.780.680.655
0 references
Microsoft Academic ID
2779496540
0 references
Homosaurus ID (V2) English
prep
0 references
National Library of Israel J9U ID
987007405858105171
1 reference
stated in
Q188915 (Deleted Item)
Homosaurus ID (V3) English
homoit0001130
named as
PrEP
alternative names
Pre-exposure prophylaxis
scope note English
Medication taken to prevent the contraction of HIV (English)
0 references
FAST ID
1983302
0 references
 
Retrieved from ‘https://stockhub.co/index.php?title=Item:Q7239230&oldid=5246821’